logo

News

hidden spacer image
DNA underlay

Category: Corporate/Financial News

adnas logo

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

June 30th, 2025

Read More

Dr. James Hayward

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

June 17th, 2025

Read More

adnas logo

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3’25 Financial Results Report in Mid-August 

June 16th, 2025

Read More

adnas logo

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

May 29th, 2025

Read More

adnas logo

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

May 15th, 2025

Read More

adnas logo

APDN Reminds Shareholders to Vote Ahead of Special Meeting on February 14

February 11th, 2025

Read More

adnas logo

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

January 8th, 2025

Read More

adnas logo

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

December 17th, 2024

Read More

adnas logo

APDN to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

December 16th, 2024

Read More